Safety, tolerability, pharmacokinetics, and pharmacodynamics of oral JNJ-64794964, a TLR-7 agonist, in healthy adults.
Gane E, Pastagia M, Schwertschlag U, De Creus A, Schwabe C, Vandenbossche J, Slaets L, Fevery B, Smyej I, Wu LS, Li R, Siddiqui S, Oey A, Musto C, Van Remoortere P.
Gane E, et al. Among authors: vandenbossche j.
Antivir Ther. 2021 May;26(3-5):58-68. doi: 10.1177/13596535211056581. Epub 2021 Oct 27.
Antivir Ther. 2021.
PMID: 35485332